Hormone Refractory Prostate Cancer Analysis 2015 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Hormone Refractory Prostate Cancer Analysis 2015

Description:

LifeScienceIndustryResearch.com adds “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H1 2015” to its store. This report provides comprehensive information on the therapeutic development for Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various stages. – PowerPoint PPT presentation

Number of Views:57

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Hormone Refractory Prostate Cancer Analysis 2015


1
Hormone Refractory (Castration Resistant,
Androgen-Independent) Prostate Cancer Pipeline
Review, H1 2015 By Life Science Industry Research
  • Browse more reports on Medical devices at
    http//www.lifescienceindustryresearch.com/categor
    y/medical-devices .

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
2
Hormone Refractory (Castration Resistant,
Androgen-Independent) Prostate Cancer Pipeline
Review, H1 2015
  • Global Markets Directs, Hormone Refractory
    (Castration Resistant, Androgen-Independent)
    Prostate Cancer Pipeline Review, H1 2015',
    provides an overview of the Hormone Refractory
    (Castration Resistant, Androgen-Independent)
    Prostate Cancers therapeutic pipeline.
  • This report provides comprehensive information on
    the therapeutic development for Hormone
    Refractory (Castration Resistant,
    Androgen-Independent) Prostate Cancer, complete
    with comparative analysis at various stages,
    therapeutics assessment by drug target, mechanism
    of action (MoA), route of administration (RoA)
    and molecule type, along with latest updates, and
    featured news and press releases.
  • Complete report available at http//www.lifescienc
    eindustryresearch.com/hormone-refractory-castratio
    n-resistant-androgen-independent-prostate-cancer-p
    ipeline-review-h1-2015.html .

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
3
Hormone Refractory (Castration Resistant,
Androgen-Independent) Prostate Cancer Pipeline
Review, H1 2015
  • Global Markets Directs report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications. The report is built using data and
    information sourced from Global Markets Directs
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by Global Markets Directs team.
    Drug profiles/records featured in the report
    undergoes periodic updation following a stringent
    set of processes that ensures that all the
    profiles are updated with the latest set of
    information.

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
4
Hormone Refractory (Castration Resistant,
Androgen-Independent) Prostate Cancer Pipeline
Review, H1 2015
  • Scope
  • The report provides a snapshot of the global
    therapeutic landscape of Hormone Refractory
    (Castration Resistant, Androgen-Independent)
    Prostate Cancer.
  • The report reviews key pipeline products under
    drug profile section which includes product
    description, MoA and RD brief, licensing and
    collaboration details other developmental
    activities.
  • The report reviews key players involved in the
    therapeutics development for Hormone Refractory
    (Castration Resistant, Androgen-Independent)
    Prostate Cancer and enlists all their major and
    minor projects.
  • The report summarizes all the dormant and
    discontinued pipeline projects.

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
5
Hormone Refractory (Castration Resistant,
Androgen-Independent) Prostate Cancer Pipeline
Review, H1 2015
  • Reasons to buy
  • Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies.
  • Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive advantage.
  • Develop strategic initiatives by understanding
    the focus areas of leading companies.
  • Identify and understand important and diverse
    types of therapeutics under development for
    Hormone Refractory (Castration Resistant,
    Androgen-Independent) Prostate Cancer.

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
6
Hormone Refractory (Castration Resistant,
Androgen-Independent) Prostate Cancer Pipeline
Review, H1 2015
  • For more details contact Mr. Ritesh Tiwari
    sales_at_lifescienceindustryresearch.com /
    18883915441

Life Science Industry Research lifescienceindustry
research.com, an online repository of market 
research reports, offers in-depth analysis of
over 5000 market segments. Life Science Industry
Research library has syndicated reports by
leading market research  publishers across the
globe.

http//www.lifescienceindustryresearch.com/
sales_at_lifescienceindustryresearch.com 1 888
391 5441
About PowerShow.com